Resmed Inc RMD:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 4:00 PM EDT

219.97UNCH (UNCH)

Volume

30,579

219.97

-0.66 (-0.30%)

Volume

618,457

52 week range

132.24 - 231.50

Open220.14
Day High222.96
Day Low218.80
Prev Close220.63
52 Week High231.50
52 Week High Date05/16/23
52 Week Low132.24
52 Week Low Date10/27/23

Key Stats

Market Cap32.315B
Shares Out146.91M
10 Day Average Volume0.81M
Dividend1.92
Dividend Yield0.87%
Beta0.70
YTD % Change27.87

KEY STATS

Open220.14
Day High222.96
Day Low218.80
Prev Close220.63
52 Week High231.50
52 Week High Date05/16/23
52 Week Low132.24
52 Week Low Date10/27/23
Market Cap32.315B
Shares Out146.91M
10 Day Average Volume0.81M
Dividend1.92
Dividend Yield0.87%
Beta0.70
YTD % Change27.87

RATIOS/PROFITABILITY

EPS (TTM)6.50
P/E (TTM)33.86
Fwd P/E (NTM)27.07
EBITDA (TTM)1.47B
ROE (TTM)22.39%
Revenue (TTM)4.584B
Gross Margin (TTM)55.78%
Net Margin (TTM)20.91%
Debt To Equity (MRQ)21.75%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date05/08/2024
Div Amount0.48
Split Date-
Split Factor-

Latest On Resmed Inc

Resmed CEO Mick Farrell goes one-on-one with Jim CramerApril 29, 2024CNBC.com
Stocks making the biggest moves midday: Microsoft, Alphabet, Snap and moreApril 26, 2024CNBC.com
Stocks making the biggest moves midday: United Airlines, Travelers, Abbott LabsApril 17, 2024CNBC.com
Stocks making the biggest premarket moves: Eli Lilly, Travelers, Alcoa and moreApril 17, 2024CNBC.com

Content From Our Affiliates

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy6 Hours AgoTipRanks
ResMed price target raised to $195 from $180 at UBSApril 28, 2024TipRanks
ResMed price target lowered to $200 from $205 at OppenheimerApril 26, 2024TipRanks
ResMed price target raised to $236 from $224 at NeedhamApril 26, 2024TipRanks
ResMed price target raised to $200 from $187 at RBC CapitalApril 26, 2024TipRanks

Profile

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB...

Michael Farrell

Chairman of the Board, Chief Executive Officer

Peter Farrell Ph.D.

Chairman Emeritus

Brett Sandercock

Chief Financial Officer

Urvashi Tyagi

Chief Technology Officer

Todd Friedman

Chief Information Security Officer

Michael Rider

General Counsel, Company Secretary, Chief Legal Officer

Address

9001 Spectrum Center Blvd

San Diego, CA

92123-1438

United States

https://www.resmed.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
STE STERIS plc	230.73	-4.73	-2.01%
IDXX IDEXX Laboratories Inc	540.94	-7.59	-1.38%
HOLX Hologic Inc	74.95	+0.09	+0.12%
WAT Waters Corp	360.51	-1.28	-0.35%
ZBH Zimmer Biomet Holdings Inc	121.23	+0.25	+0.21%